Clin2
NCT07580105Likely a fitRecruiting

AI tool to help diagnose breast cancer from MRI scans

Breast Cancer

Part of Cancer, Skin clinical trials.

This study tests a new artificial intelligence software called Kenko Breast AI+ that analyzes breast MRI scans to help doctors better detect and monitor breast cancer. If you've had or are planning to have a breast MRI for cancer concerns, this trial might be right for you.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are a woman age 18 or older
  • You have had a breast MRI scan that included special imaging sequences (perfusion, diffusion, and T2 imaging)
  • Your MRI was done for cancer staging, checking response to treatment, evaluating high cancer suspicion, or follow-up monitoring
  • If your MRI was for follow-up, you must have a previous MRI from within the last 12 months available
  • You are not pregnant
  • Your MRI images are complete and of good quality (not incomplete or invalid)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07327970Recruiting
AI test to predict breast cancer treatment response

This study tests whether an AI tool can predict how well breast cancer responds to chemotherapy given before surgery. Your tumor sample from a needle biopsy will be analyzed to see if the AI's prediction matches your actual treatment outcome.

Incheon
NCT05800132Recruiting
AI helps review routine breast mammograms for screening

This study tests whether an artificial intelligence (AI) system can help a second reader interpret routine breast screening mammograms. It may improve how consistently images are assessed, especially when the first reader calls them normal or benign.

Aubagne
NCT06649565Recruiting
AI model to predict breast cancer treatment response

This trial uses an artificial intelligence model to predict how well breast cancer responds to neoadjuvant therapy (treatment before surgery). It aims to improve treatment planning by analyzing MRI scans taken before and after therapy.

Beijing, Beijing Municipality
NCT06717984Recruiting
AI model for breast cancer from tissue images

This trial tests an artificial intelligence (AI) model that looks at pictures of breast tissue to find cancer. It may help improve early detection and reduce the need for invasive tests.

Dhaka
NCT07244094Recruiting
AI predicts breast cancer spread risk from tissue scans

This trial uses artificial intelligence to analyze images of your tumor tissue to predict if breast cancer might spread to other parts of the body. It may help doctors better understand your individual risk and guide treatment decisions.

Changchun, Jilin
NCT06266026Recruiting
AI-enhanced thermal imaging for breast cancer screening

This study tests a new, non-contact thermal camera (thermography) combined with artificial intelligence to find breast cancer. It is designed for women coming for routine screening, high-risk screening, or diagnostic exams, and aims to see if this painless, radiation-free method can help detect cancer earlier.

Heidelberg

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.